secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K/A
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0000950170-24-084024
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 9.01, 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics files Charter Amendment for 1-for-10 reverse stock split effective July 17, 2024
--------------------------------------------------------------------------------

- Reverse stock split at ratio 1-for-10; effective July 17, 2024 at 5:00 p.m. ET.
- Every 10 pre-split shares automatically converted to 1 post-split share; par value unchanged.
- Stock continues trading on Nasdaq under symbol TCRT; new CUSIP number 98973P309 effective July 18.
- Stockholders approved reverse split at June 6, 2024 annual meeting; board set final ratio on June 26, 2024.
- Equiniti Trust Company appointed as exchange agent for the split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024084024/0000950170-24-084024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017024084024/tcrt-20240716.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-084024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer